Supramolecular coordination complexes as diagnostic and therapeutic agents.
Cancer
Metals in medicine
Supramolecular coordination complex
Theranostics
Journal
Current opinion in chemical biology
ISSN: 1879-0402
Titre abrégé: Curr Opin Chem Biol
Pays: England
ID NLM: 9811312
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
01
05
2020
revised:
18
08
2020
accepted:
30
08
2020
pubmed:
5
11
2020
medline:
15
9
2021
entrez:
4
11
2020
Statut:
ppublish
Résumé
The metal-based drugs represented by cisplatin, carboplatin, and oxaliplatin, prevail in cancer treatment, whereas new therapeutics are extremely slow to step into the clinic. Poor pharmacokinetics, multidrug resistance, and severe side effects greatly limit the development of metal-based anticancer drugs. The robustness and modular composition of supramolecular coordination complexes allow for the incorporation of novel diagnostic and therapeutic modalities, showing promising potentials for precise cancer theranostics. In this mini review, we highlight the recent advances in the development of supramolecular coordination complexes as diagnostic and therapeutic agents. The key focuses of these reports lie in searching sophisticated coordination ligands and nanoformulations that can potentially solve the issues faced by current metal-based drugs including imaging, resistance, toxicity, and pharmacological deficiencies.
Identifiants
pubmed: 33147551
pii: S1367-5931(20)30121-6
doi: 10.1016/j.cbpa.2020.08.007
pmc: PMC8062580
mid: NIHMS1633016
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Coordination Complexes
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
19-31Subventions
Organisme : Intramural NIH HHS
ID : ZIA EB000073
Pays : United States
Informations de copyright
Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Theranostics. 2019 May 15;9(11):3041-3074
pubmed: 31244941
Adv Drug Deliv Rev. 2018 Jul;132:104-138
pubmed: 30415656
J Am Chem Soc. 2019 Sep 11;141(36):14005-14020
pubmed: 31419112
J Am Chem Soc. 2019 Jun 5;141(22):8943-8950
pubmed: 31088049
Organometallics. 2011 Dec 12;30(23):6482-6489
pubmed: 22180698
Chem Commun (Camb). 2011 May 14;47(18):5184-6
pubmed: 21451846
Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20296-20302
pubmed: 31548389
Chem Sci. 2015 Feb 1;6(2):1189-1193
pubmed: 25621144
Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16729-16735
pubmed: 31391305
J Am Chem Soc. 2017 Nov 8;139(44):15940-15949
pubmed: 29019660
Chem Commun (Camb). 2008 Dec 7;(45):5896-908
pubmed: 19030534
Chem Commun (Camb). 2019 Jul 9;55(56):8036-8059
pubmed: 31206102
Theranostics. 2016 Jun 15;6(9):1362-77
pubmed: 27375785
Nat Commun. 2018 Feb 22;9(1):766
pubmed: 29472567
Curr Opin Chem Biol. 2015 Oct;28:29-38
pubmed: 26056952
Chembiochem. 2014 Mar 21;15(5):695-700
pubmed: 24677392
Chem Soc Rev. 2017 Nov 13;46(22):7021-7053
pubmed: 28980674
Chem Sci. 2019 Jun 13;10(29):7023-7028
pubmed: 31588269
Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):1968-1973
pubmed: 30670648
Nat Commun. 2018 Oct 18;9(1):4335
pubmed: 30337535
Dalton Trans. 2015 Jun 28;44(24):11129-36
pubmed: 25997516
Chemistry. 2017 Dec 6;23(68):17199-17203
pubmed: 28961334
Bioconjug Chem. 2018 Nov 21;29(11):3856-3865
pubmed: 30380298
Acc Chem Res. 2013 Nov 19;46(11):2441-53
pubmed: 23742638
Chem Rev. 2016 Mar 9;116(5):3436-86
pubmed: 26865551
Theranostics. 2019 May 18;9(11):3150-3169
pubmed: 31244947
Nat Rev Cancer. 2017 Jan;17(1):20-37
pubmed: 27834398
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4090-4098
pubmed: 30765514
Front Chem. 2018 Dec 14;6:620
pubmed: 30619828
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11100-11105
pubmed: 27647900
ACS Nano. 2013 Jul 23;7(7):5654-9
pubmed: 23837396
Chem Rev. 2015 Nov 11;115(21):11718-940
pubmed: 26492387
Angew Chem Int Ed Engl. 2010 Aug 23;49(36):6260-6
pubmed: 20652915
Chem Commun (Camb). 2018 Jan 18;54(7):731-734
pubmed: 29303526
J Am Chem Soc. 2015 Dec 9;137(48):15276-86
pubmed: 26550682
Nat Rev Mater. 2017;2:
pubmed: 29075517
Chem Commun (Camb). 2018 Jul 17;54(58):8068-8071
pubmed: 29968880
Chemistry. 2013 Jun 24;19(26):8378-86
pubmed: 23737435
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):13720-13725
pubmed: 27856738
J Inorg Biochem. 2019 Oct;199:110781
pubmed: 31357067
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6618-6623
pubmed: 30894484
Nat Rev Cancer. 2005 Jan;5(1):65-72
pubmed: 15630416
Curr Opin Chem Biol. 2014 Apr;19:144-53
pubmed: 24608084
Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):8087-8092
pubmed: 30038010
Organometallics. 2012 May 14;31(9):3519-3526
pubmed: 22639481
Nat Chem. 2014 Sep;6(9):797-803
pubmed: 25143215
Nat Rev Cancer. 2014 Mar;14(3):199-208
pubmed: 24561446
Inorg Chem. 2017 Jul 17;56(14):8430-8438
pubmed: 28665136
Inorg Chem. 2017 Dec 18;56(24):14715-14729
pubmed: 29172467
Chem Rev. 2019 Aug 28;119(16):9559-9656
pubmed: 31287663
Nat Chem. 2015 Apr;7(4):342-8
pubmed: 25803473
Inorg Chem. 2017 Apr 17;56(8):4616-4622
pubmed: 28383898
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18448-53
pubmed: 25516985
J Am Chem Soc. 2018 Dec 12;140(49):16877-16881
pubmed: 30485075
Proc Natl Acad Sci U S A. 2018 May 29;115(22):5664-5669
pubmed: 29760069
J Am Chem Soc. 2018 Jun 20;140(24):7730-7736
pubmed: 29787269
Acc Chem Res. 2013 Nov 19;46(11):2464-74
pubmed: 23786636
Theranostics. 2014 Mar 26;4(6):660-77
pubmed: 24723986
Chem Rev. 2019 Jan 23;119(2):1138-1192
pubmed: 30299085
J Am Chem Soc. 2016 Nov 2;138(43):14488-14496
pubmed: 27723965
Chemistry. 2013 Aug 26;19(35):11622-8
pubmed: 23852626
Dalton Trans. 2018 Jan 15;47(3):670-674
pubmed: 29257160
Chemistry. 2014 Oct 27;20(44):14410-20
pubmed: 25209962